Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 11, Number 9—September 2005

Research

Molecular Epidemiology of SARS-associated Coronavirus, Beijing

Wei Liu*, Fang Tang*, Arnaud Fontanet†, Lin Zhan*, Tian-Bao Wang‡, Pan-He Zhang*, Yi-He Luan‡, Chao-Yang Cao‡, Qiu-Min Zhao*, Xiao-Ming Wu*, Zhong-Tao Xin§, Shu-Qing Zuo*, Laurence Baril†, Astrid Vabret¶, Yi-Ming Shao#, Hong Yang*, and Wu-Chun Cao*Comments to Author 
Author affiliations: *Beijing Institute of Microbiology and Epidemiology, Beijing, People's Republic of China; †Institut Pasteur, Paris, France; ‡Beijing Armed Force Hospital, Beijing, People's Republic of China; §Beijing Institute of Basic Medical Sciences, Beijing, People's Republic of China; ¶Caen University, Caen, France; #Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China

Main Article

Table 2

Epidemiologic and phylogenetic data on 29 severe acute respiratory syndrome patients, Beijing, 2003*

Patient no. (sex, age [y]) Onset date† Sampling date,† clinical sample 5-loci genotype Other variant loci
1‡ (M, 25) 3/10 4/28, Sp GGCTC 22589
2ठ(F, 48) 3/21 4/28, Sp GGCTC 22589, 27749
3 (M, 19) 3/31 4/28, Sp; 5/5, Sp GGCTC 22589
4‡ (F, 34) 3/31 5/5, St; 4/28, Sp TGTTT 17620, 22589
5ठ(M, 21) 3/31 4/28, Sp; 5/5, Sp TGTTT 22589
6‡ (F, 34) 4/2 4/28, Sp TGTTT 22077
7 (F, 27) 4/2 4/28, Sp GGCTC 22589
8‡ (M, 31) 4/3 4/28, Sp TGTTT 22077, 22589, 27749
9‡ (M, 20) 4/5 5/5, Sp; 4/28, Sp TGTTT 17620, 22077, 22589
10 (F, 23) 4/8 5/22, St; 5/15, Sp GGCTC 22589
11§ (M, 47) 4/8 5/5-Sp; 5/5, St GGCTC 22589
12 (M, 73) 4/9 4/28, Sp; 4/28, St TGTTT 22589, 27749
13 (M, 54) 4/9 4/28, Sp; 4/28, St GGCTC 22589, 27749
14‡ (F, 21) 4/11 4/28, Sp; 4/28, St; 5/5, Sp TGTTT
15§ (M, 61) 4/12 5/22, Sp GATTC 22589
16‡ (F, 25) 4/15 5/5, Sp TGTTT 17620, 22589, 27749
17 (M, 25) 4/17 5/5, Sp TGTTT 22077, 22589, 27749
18 (F, 20) 4/18 4/28, Sp; 4/28, St TGTTT 22589, 27749
19‡ (F, 25) 4/20 5/5, Sp; 5/5, St TGTTT 22077, 22589,
20 (F, 34) 4/21 4/28, Sp; 5/5, Sp TGTTT 22077
21 (M, 33) 4/23 5/5, Sp; 5/5 St; 4/28-Sp TGTTT 17620, 22589
22 (M, 28) 4/24 5/5, Sp TGTTT 22589, 27749
23 (M, 61) 5/1 5/15, Sp GATTC 22589
24‡ (F, 31) 5/1 5/5, Sp TGTTT 22077, 2589, 7749
25 (M, 25) 5/2 5/7, Sp TGTTT 22077
26‡ (M, 25) 5/4 5/22, Sp TGTTT 22077
27 (M, 19) 5/6 5/22, Sp TGTTT 22589, 27749
28 (F, 28) 5/7 5/22, Sp TGTTT 17620, 22589, 27749
29 (M, 22) 5/12 4/28, Sp; 5/5, Sp TGTTT 22589, 27749

*F, female; M, male; Sp, sputum; St, stool.
†All dates are in 2003.
‡Patients were from the same cluster.
§Patients with adverse clinical outcome.

Main Article

Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external